Neo Ivy Capital Management bought a new stake in MKS Instruments, Inc. (NASDAQ:MKSI - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 22,412 shares of the scientific and technical instruments company's stock, valued at approximately $2,436,000. MKS Instruments comprises approximately 0.8% of Neo Ivy Capital Management's portfolio, making the stock its 19th biggest position.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Barclays PLC boosted its position in MKS Instruments by 108.6% during the third quarter. Barclays PLC now owns 1,019,134 shares of the scientific and technical instruments company's stock worth $110,789,000 after purchasing an additional 530,620 shares during the period. Shellback Capital LP purchased a new stake in shares of MKS Instruments during the second quarter worth $34,541,000. Millennium Management LLC boosted its holdings in shares of MKS Instruments by 219.5% in the second quarter. Millennium Management LLC now owns 348,024 shares of the scientific and technical instruments company's stock worth $45,445,000 after acquiring an additional 239,099 shares during the period. Artemis Investment Management LLP purchased a new position in shares of MKS Instruments in the third quarter valued at $21,690,000. Finally, Mizuho Markets Americas LLC bought a new stake in shares of MKS Instruments during the 2nd quarter valued at $23,171,000. 99.79% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other news, Director Jacqueline F. Moloney sold 250 shares of the company's stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $108.90, for a total value of $27,225.00. Following the sale, the director now directly owns 10,283 shares of the company's stock, valued at $1,119,818.70. This represents a 2.37 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elizabeth Mora sold 275 shares of MKS Instruments stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $113.41, for a total transaction of $31,187.75. Following the transaction, the director now directly owns 17,659 shares of the company's stock, valued at approximately $2,002,707.19. This trade represents a 1.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.51% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on MKSI. The Goldman Sachs Group initiated coverage on MKS Instruments in a research report on Tuesday, September 3rd. They set a "neutral" rating and a $129.00 price target on the stock. Wells Fargo & Company cut their price target on shares of MKS Instruments from $120.00 to $110.00 and set an "equal weight" rating for the company in a report on Thursday, October 3rd. Mizuho raised shares of MKS Instruments to a "strong-buy" rating in a report on Monday, October 7th. Citigroup cut MKS Instruments from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $145.00 to $120.00 in a research report on Monday, September 16th. Finally, Cantor Fitzgerald started coverage on MKS Instruments in a report on Tuesday, September 10th. They issued an "overweight" rating and a $140.00 price target on the stock. Five investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, MKS Instruments presently has a consensus rating of "Moderate Buy" and a consensus target price of $141.09.
Read Our Latest Stock Analysis on MKS Instruments
MKS Instruments Trading Up 2.3 %
MKS Instruments stock traded up $2.51 during mid-day trading on Wednesday, hitting $113.42. The company's stock had a trading volume of 130,993 shares, compared to its average volume of 820,730. The business has a 50 day moving average price of $108.20 and a 200-day moving average price of $117.23. MKS Instruments, Inc. has a 12 month low of $85.25 and a 12 month high of $147.40. The stock has a market cap of $7.63 billion, a price-to-earnings ratio of 246.47, a price-to-earnings-growth ratio of 0.67 and a beta of 1.65. The company has a debt-to-equity ratio of 1.98, a current ratio of 3.42 and a quick ratio of 2.21.
MKS Instruments (NASDAQ:MKSI - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The scientific and technical instruments company reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.27. MKS Instruments had a return on equity of 15.79% and a net margin of 0.90%. The firm had revenue of $896.00 million during the quarter, compared to the consensus estimate of $874.29 million. During the same quarter in the previous year, the company posted $1.46 earnings per share. The business's revenue was down 3.9% on a year-over-year basis. As a group, analysts forecast that MKS Instruments, Inc. will post 6.33 EPS for the current year.
MKS Instruments Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 25th were given a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date was Monday, November 25th. MKS Instruments's payout ratio is 195.56%.
MKS Instruments Company Profile
(
Free Report)
MKS Instruments, Inc provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments.
Further Reading
Before you consider MKS Instruments, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MKS Instruments wasn't on the list.
While MKS Instruments currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.